Clinical Context
A typical patient receiving J0216 (injection, alfentanil hydrochloride, 500 micrograms) is an adult undergoing a short-duration painful procedure in the outpatient surgical or procedural setting where a short-acting opioid is required for analgesia or sedation. Common scenarios include monitored anesthesia care for brief diagnostic procedures (e.g., endoscopy, ophthalmologic procedures, minor ENT interventions), perioperative analgesia for short ambulatory surgeries, or intra-procedural pain control in the ambulatory surgical center.
The clinical workflow begins with pre-procedure evaluation by the proceduralist or anesthesia provider who documents indication for short-acting opioid analgesia, medical history, airway assessment, and informed consent. On the day of service, standard monitoring (continuous pulse oximetry, blood pressure, ECG as indicated) is applied. A qualified provider (anesthesiologist, CRNA, or proceduralist in accordance with facility policy) administers J0216 intravenously, titrating to effect for analgesia or adjunctive sedation. Post-administration monitoring occurs in the PACU or recovery area until discharge criteria are met. Documentation includes medication name, dose, route, time, patient's response, vital signs, and any airway or respiratory interventions.